share_log

安旭生物关于对上海证券交易所2023年年度报告问询函回复的公告

An Xu Biotech's announcement on the response to the inquiry letter on the 2023 annual report of the Shanghai Stock Exchange

Sensex a share ·  May 26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more